1. Home
  2. ESPR vs MEC Comparison

ESPR vs MEC Comparison

Compare ESPR & MEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • MEC
  • Stock Information
  • Founded
  • ESPR 2008
  • MEC 1945
  • Country
  • ESPR United States
  • MEC United States
  • Employees
  • ESPR N/A
  • MEC N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • MEC Industrial Specialties
  • Sector
  • ESPR Health Care
  • MEC Industrials
  • Exchange
  • ESPR Nasdaq
  • MEC Nasdaq
  • Market Cap
  • ESPR 445.6M
  • MEC 329.4M
  • IPO Year
  • ESPR 2013
  • MEC 2019
  • Fundamental
  • Price
  • ESPR $2.72
  • MEC $14.14
  • Analyst Decision
  • ESPR Buy
  • MEC Strong Buy
  • Analyst Count
  • ESPR 6
  • MEC 3
  • Target Price
  • ESPR $6.50
  • MEC $21.33
  • AVG Volume (30 Days)
  • ESPR 6.0M
  • MEC 110.1K
  • Earning Date
  • ESPR 11-06-2025
  • MEC 11-04-2025
  • Dividend Yield
  • ESPR N/A
  • MEC N/A
  • EPS Growth
  • ESPR N/A
  • MEC 64.18
  • EPS
  • ESPR N/A
  • MEC 0.86
  • Revenue
  • ESPR $268,125,000.00
  • MEC $524,606,000.00
  • Revenue This Year
  • ESPR $9.87
  • MEC N/A
  • Revenue Next Year
  • ESPR N/A
  • MEC $17.38
  • P/E Ratio
  • ESPR N/A
  • MEC $16.69
  • Revenue Growth
  • ESPR N/A
  • MEC N/A
  • 52 Week Low
  • ESPR $0.69
  • MEC $11.72
  • 52 Week High
  • ESPR $3.94
  • MEC $23.02
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 70.47
  • MEC 43.67
  • Support Level
  • ESPR $2.37
  • MEC $14.11
  • Resistance Level
  • ESPR $2.90
  • MEC $15.53
  • Average True Range (ATR)
  • ESPR 0.17
  • MEC 0.54
  • MACD
  • ESPR 0.00
  • MEC 0.03
  • Stochastic Oscillator
  • ESPR 77.78
  • MEC 9.15

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About MEC Mayville Engineering Company Inc.

Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.

Share on Social Networks: